Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Background: Following remission of an anxiety disorder or a depressive disorder, antidepressants are frequently discontinued and in the case of symptom occurrence reinstated. Reinstatement of antidepressants seems less effective in some patients, but an overview is lacking. This systematic review aimed to provide insight into the magnitude and risk factors of response failure after reinstatement of antidepressants in patients with anxiety disorders, depressive disorders, obsessive-compulsive disorder (OCD), or posttraumatic stress disorder (PTSD). Method: PubMed, Embase, and trial registers were systematically searched for studies in which patients: (1) had an anxiety disorder, a depressive disorder, OCD, or PTSD and (2) experienced failure to respond after reinstatement of a previously effective antidepressant. Results: Ten studies reported failure to respond following antidepressant reinstatement. The phenomenon was observed in 16.5% of patients with a depressive disorder, OCD, and social phobia and occurred in all common classes of antidepressants. The range of response failure was broad, varying between 3.8 and 42.9% across studies. No risk factors for failure to respond were investigated. The overall study quality was limited. Conclusion: Research investigating response failure is scarce and the study quality limited. Response failure occurred in a substantial minority of patients. Contributors to the relevance of this phenomenon are the prevalence of the investigated disorders, the number of patients being treated with antidepressants, and the occurrence of response failure for all common classes of antidepressants. This systematic review highlights the need for studies systematically investigating this phenomenon and associated risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a recent systematic review on lack of response to re-challenge,22 the range of response failures was broad (between 4.9% and 42.9% across studies).”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [22]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Persistent post-withdrawal disorders, that is a condition in which rebound symptoms and/or new withdrawal symptoms and/or emerging new psychotic symptoms of another type, such as disorganized behavior, persist longer than 6 weeks, have been described after discontinuation of antipsychotics.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“2 specific persistent post-withdrawal disorders, named persistent post-withdrawal tardive dyskinesia and persistent post-withdrawal supersensitivity psychosis, have been well described [21, 22, 150, 151].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“and that 2 persistent post-withdrawal disorders, tardive dyskinesia and supersensitivity psychosis, were specifically induced by antipsychotics [21, 22, 150, 151].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1359 · Cited by 2,947
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
Bruce, S. E., Yonkers, K. A., Otto, M. W., Eisen, J. L., Weisberg, R. B., Pagano, M., Shea, M. T., & Keller, M. B. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1179 · Cited by 963
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Multiple recurrences of major depressive disorder
Solomon, D. A., Keller, M. B., Leon, A. C., Mueller, T. I., Lavori, P. W., Shea, M. T., Coryell, W., Warshaw, M., Turvey, C., Maser, J. D., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.229 · Cited by 835 · cited 1×
“For depressive disorders, it is known that with an increasing number of episodes the likelihood of symptom occurrence also increases [50–53], potentially resulting in a chronic course with a more severe symptomatology [54].”
BackgroundBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
The ESEMeD/MHEDEA 2000 investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00330.x · Cited by 519
Maintenance Treatment of Major Depression in Old Age
Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052619 · Cited by 476
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials
Pildal, J., Hrobjartsson, A., Jorgensen, K., Hilden, J., Altman, D., & Gotzsche, P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym087 · Cited by 472
The Clinical Course of Unipolar Major Depressive Disorders
Judd, L. L. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230015002 · Cited by 460
Yonkers, K. A., Bruce, S. E., Dyck, I. R., & Keller, M. B. (2003) · Depression and Anxiety · doi:10.1002/da.10106 · Cited by 404
Six-Year Outcome for Cognitive Behavioral Treatment of Residual Symptoms in Major Depression
Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., & Morphy, M. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1443 · Cited by 299 · cited 9×
“…had occurred [37, 42], the dose and frequency of antidepressant treatment and reinstatement [37, 42], the duration of the treatment [37, 41–44], the duration of reinstatement [37, 38, 41–44], and the plasma levels of tricyclic antidepressants during treatment and/ or reinstatement [37–39, 42, 44].”
BackgroundMethodInfluentialCYP induction-mediated drug interactions: in vitro assessment and clinical implications
Lin, J. H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0277-7 · Cited by 264
Kessing, L. V., Hansen, M. G., Andersen, P. K., & Angst, J. (2004) · Acta Psychiatrica Scandinavica · doi:10.1046/j.1600-0447.2003.00266.x · Cited by 258
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
Stoolmiller, M., Kim, H. K., & Capaldi, D. M. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.3.331 · Cited by 183
Li, C.-T., Bai, Y.-M., Huang, Y.-L., Chen, Y.-S., Chen, T.-J., Cheng, J.-Y., & Su, T.-P. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.086983 · Cited by 177
The natural course of social anxiety disorder among adolescents and young adults
Beesdo‐Baum, K., Knappe, S., Fehm, L., Höfler, M., Lieb, R., Hofmann, S. G., & Wittchen, H. ‐. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01886.x · Cited by 167
A Longitudinal Typology of Symptoms of Depression and Anxiety Over the Life Course
Colman, I., Ploubidis, G. B., Wadsworth, M. E. J., Jones, P. B., & Croudace, T. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.012 · Cited by 167
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
The mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158 · cited 2×
“The op-positional model of tolerance states that it cannot be excluded that antidepressants have a detrimental effect on the course of illness in anxiety disorders and depressive disorders [29, 30].”
BackgroundBatelaan, N. M., Bosman, R. C., Muntingh, A., Scholten, W. D., Huijbregts, K. M., & van Balkom, A. J. L. M. (2017) · BMJ · doi:10.1136/bmj.j3927 · Cited by 153
Self-citationThe Advantage of Early Treatment Intervention in Recurrent Depression
(1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810090013002 · Cited by 150
Loss of Antidepressant Efficacy During Maintenance Therapy: Possible Mechanisms and Treatments
Byrne, S. E., & Rothschild, A. J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0602 · Cited by 149
Kaymaz, N., van Os, J., Loonen, A. J. M., & Nolan, W. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0910 · Cited by 135 · cited 1×
“Given that a decrease in the effect of antidepressants has also been reported during continuous antidepressant use [3–7], with repeated exposures [8–10], and in patients with recurrent episodes [49], it is possible that these different types of response failures reflect a broader phenomenon.”
BackgroundOlino, T. M., Klein, D. N., Lewinsohn, P. M., Rohde, P., & Seeley, J. R. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2009.07.002 · Cited by 124
Continuation and Maintenance Use of Antidepressants in Recurrent Depression
Bockting, C. L. H., ten Doesschate, M. C., Spijker, J., Spinhoven, P., Koeter, M. W. J., & Schene, A. H. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000110056 · Cited by 121
(2006) · PubMed · Cited by 100
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95
Course trajectories of unipolar depressive disorders identified by latent class growth analysis
Rhebergen, D., Lamers, F., Spijker, J., de Graaf, R., Beekman, A. T. F., & Penninx, B. W. J. H. (2012) · Psychological Medicine · doi:10.1017/s0033291711002509 · Cited by 88
Leykin, Y., Amsterdam, J. D., DeRubeis, R. J., Gallop, R., Shelton, R. C., & Hollon, S. D. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.2.267 · Cited by 82
Huijbregts, K. M., Hoogendoorn, A., Slottje, P., van Balkom, A. J. L. M., & Batelaan, N. M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000480456 · Cited by 68
Self-citationPosternak, M. A., & Zimmerman, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0605 · Cited by 67
Management of recurrent depression.
Kupfer, D. J. (1993) · PubMed · Cited by 65
Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose.
D, M. F. M., Rappe, S., Pava, J. A., Nierenberg, A. A., Alpert, J. E., & Rosenbaum, J. F. (1995) · PubMed · Cited by 63
Two‐year course of anxiety disorders: different across disorders or dimensions?
Hendriks, S. M., Spijker, J., Licht, C. M. M., Beekman, A. T. F., & Penninx, B. W. J. H. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12024 · Cited by 55
Maina, G., Albert, U., & Bogetto, F. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200101000-00004 · Cited by 52
Treatment of consecutive episodes of major depression in the elderly
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1740 · Cited by 52
Social phobia: long-term treatment outcome and prediction of response - a moclobemide study
Versiani, M., Amrein, R., & Montgomery, S. A. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199709000-00001 · Cited by 48
Flint, A. J., & Rifat, S. L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.943 · Cited by 47
Skipstein, A., Janson, H., Stoolmiller, M., & Mathiesen, K. S. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-589 · Cited by 46
Bulloch, A., Williams, J., Lavorato, D., & Patten, S. (2014) · Depression and Anxiety · doi:10.1002/da.22173 · Cited by 45
Two-Year Course Trajectories of Anxiety Disorders: Do DSM Classifications Matter?
Batelaan, N. M., Rhebergen, D., Spinhoven, P., van Balkom, A. J., & Penninx, B. W. J. H. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08837 · Cited by 45
Self-citationNay, W. T., Brown, R. C., & Roberson‐Nay, R. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.03.006 · Cited by 45
Treatment Approaches to Major Depressive Disorder Relapse
Fava, M., Schmidt, M. E., Zhang, S., Gonzales, J., Raute, N. J., & Judge, R. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000063644 · Cited by 44
Amsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F. (2009) · Neuropsychobiology · doi:10.1159/000226611 · Cited by 39
Management of depression relapse: Re-initiation of duloxetine treatment or dose increase
Fava, M., Detke, M. J., Balestrieri, M., WANG, F., Raskin, J., & David, P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.06.005 · Cited by 39
Loss of drug effects during continuation therapy
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.562 · Cited by 36
Menzies, D. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0719 · Cited by 35
Francis, J. L., Wiesberg, R. B., Dyck, I. R., Culpepper, L., Smith, K., Orlando Edelen, M., & Keller, M. B. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0301 · Cited by 34
Tolerance to phenelzine and subsequent refractory depression: three cases.
Donaldson (1989) · PubMed · Cited by 26
Retreatment for relapse following desipramine discontinuation in dysthymia
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.6.926 · Cited by 15
Differential Responses to a Single Antidepressant in Recurrent Episodes of Major Depression
Remillard, A. J., Blackshaw, S. L., & Dangor, A. (1994) · Psychiatric Services · doi:10.1176/ps.45.4.359 · Cited by 12
Clomipramine-resistant, fluoxetine-responsive obsessive compulsive disorder: a case report.
Paholpak, S. (2002) · PubMed · Cited by 1
Research works printed but not linked: 1
- 31 Menzies D: Systematic reviews and metaanalyses. Int J Tuberc Lung Dis 2011; 15: 582593.
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Fava, G. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320970325 · Cited by 84
Iatrogenic Factors in Psychopathology
Fava, G. A., & Rafanelli, C. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500151 · Cited by 82
Discontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience
Fava, G. A., & Belaise, C. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000492693 · Cited by 77
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
Metadata
- Authors
- Bosman, R. C., Waumans, R. C., Jacobs, G. E., Oude Voshaar, R. C., Muntingh, A. D. T., Batelaan, N. M., & van Balkom, A. J. L. M.
- Affiliations
- Amsterdam Public Health (NL)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 87
- Issue
- 5
- Pages
- 268-275
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- PMC
- PMC6191880
- OpenAlex
- W2884591456
- Cited by
- 21
- References
- 60
- Citations by year
- 2026: 3 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 5 · 2019: 2
- FWCI
- 0.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Pure Amsterdam UMC (acceptedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Amsterdam University Medical Centers
- Vrije Universiteit Amsterdam
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressant discontinuation, depression, anxiety disorders, obsessive-compulsive disorder, post-traumatic stress disorder, social anxiety disorder, risk factors for treatment failure
- MeSH terms
- Antidepressive Agents, Anxiety Disorders, Depressive Disorder, Humans, Obsessive-Compulsive Disorder, Stress Disorders, Post-Traumatic, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.